Category Archives: Cancer: Multiple Myeloma

Multiple myeloma and myeloid leukemia therapies could be enhanced with experimental drug

A pre-clinical study led by Virginia Commonwealth University Massey Cancer Center and Department of Internal Medicine researchers suggests that an experimental drug known as dinaciclib could improve the effectiveness of certain multiple myeloma and myeloid leukemia therapies. The study, recently … Continue reading

Posted in Cancer: Leukemia, Cancer: Multiple Myeloma | Comments Off

Alcohol consumption tied to reduced cancer risk in new, large study

Cancer Epidemiol Biomarkers Prev. 2013 Aug 20. [Epub ahead of print] A Pooled Analysis of Alcohol Consumption and Risk of Multiple Myeloma in the International Multiple Myeloma Consortium. Andreotti G, Birmann B, De Roos AJ, Spinelli J, Cozen W, Camp … Continue reading

Posted in Alcohol, Cancer: Multiple Myeloma | Comments Off

Multiple myeloma drug Kyprolis gets FDA approval

The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. A form of blood cancer that arises … Continue reading

Posted in Cancer: Multiple Myeloma | Comments Off

Why chemo fails

The fight against cancer is not won in a single battle: Long after a cancer has been beaten into remission, it can return. The reason for this is under debate, and much is unclear. New research led by Weizmann Institute … Continue reading

Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Bile Duct, Cancer: Bladder, Cancer: Bowel, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chemo Brain, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Eye, Cancer: Gastric, Cancer: Head, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Stomach, Cancer: Testicular, Cancer: Throat, Cancer: Thyroid, Cancer: Uterine, Chemotherapy | Comments Off

Cancer diagnostic test that may extend survival is cost effective: J Natl Cancer Inst

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their proprietary informatics platform, announced today that results from a study involving its Pathwork® Tissue of Origin Test will be presented this week at the … Continue reading

Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Bladder, Cancer: Bowel, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Eye, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Stomach, Cancer: Testicular, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval, Health Care: Technology | Comments Off

Cancer detection at inception goal of new grant

Newswise — A team of cancer imaging experts at Johns Hopkins has embarked on a five-year research initiative to speed development of early diagnostic tests and new treatments for breast, prostate and other common cancers. Using advanced imaging tools developed … Continue reading

Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Bladder, Cancer: Bowel, Cancer: Brain, Cancer: Breast, Cancer: Cell Phones, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Eye, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Stomach, Cancer: Testicular, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval | Comments Off

Advanced melanoma vaccine improves response rate, survival: first cancer vaccine to show an improved response rate in patients: NEJM

A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to research led by scientists from The University of Texas MD Anderson … Continue reading

Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Bladder, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Testicular, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval | Comments Off

Multiple myeloma survival improves with stem-cell transplant followed by lenalinomide: clinical trial conducted by the Cancer and Leukemia Group (CALGB)

Updated data from a National Cancer Institute-sponsored clinical trial conducted by the Cancer and Leukemia Group (CALGB) was presented May 5 at the 13th International Myeloma Workshop in Paris, France. The phase III study evaluated the benefits of continuous, or … Continue reading

Posted in Cancer: Multiple Myeloma, Stem Cells | Comments Off

Cancer survivors number 12,000,000 in US

The number of cancer survivors in the United States increased to 11.7 million in 2007, according to a report released by the Centers for Disease Control and Prevention and the National Cancer Institute (NCI), part of the National Institutes of … Continue reading

Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Testicular, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval | Comments Off

What all cancers have in common, updated

Renowned cancer researchers Robert Weinberg, a Founding Member of Whitehead Institute, and Douglas Hanahan, Director of the Swiss Institute for Experimental Cancer Research (ISREC) have updated their seminal review, “Hallmarks of Cancer,” which has influenced the study of cancer and … Continue reading

Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval | Comments Off

Cancer breakthrough may be possible with nanomedicine discovery

Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication’s toxic effects will no longer be an oncologist’s dream but a medical reality, thanks to the work of Professor Sylvain Martel, Director of … Continue reading

Posted in Cancer, Cancer: Acute Lymphoblastic Leukemia, Cancer: Acute Myeloid Leukemia, Cancer: Anal, Cancer: Brain, Cancer: Breast, Cancer: Cervical, Cancer: Chronic Lymphocytic Leukemia, Cancer: Colon, Cancer: Endometrial, Cancer: Esophageal, Cancer: Gastric, Cancer: Head, Cancer: Hodgkin's Lymphoma, Cancer: Kidney, Cancer: Leukemia, Cancer: Liver, Cancer: Lung, Cancer: Lymphoma, Cancer: Mantle Cell Lymphoma, Cancer: Mesothelioma, Cancer: Multiple Myeloma, Cancer: Myelodysplastic Syndromes, Cancer: Neck, Cancer: Oral, Cancer: Ovarian, Cancer: Pancreatic, Cancer: Prostate, Cancer: Skin, Cancer: Thyroid, Cancer: Uterine, Cancer: Vaginal, Cancer: Vulval, Nanotechnology and Health | Comments Off

Multiple myeloma patient lives extended by zoledronic acid: UK research

Zoledronic acid (Zometa, Reclast) extends survival in patients with multiple myeloma, researchers reported. In a randomized but not blinded trial, patients getting zoledronic acid in addition to standard anti-myeloma therapy lived a median of 5.5 months longer than those getting … Continue reading

Posted in Cancer: Multiple Myeloma | Tagged , , , , , , , | Comments Off